Moderna Inc

The CDC voted Thursday to recommend updated versions of both the Pfizer and Moderna coronavirus vaccine boosters, paving way for a widespread rollout as early as next week.

The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.

U.S. stock futures fell Wednesday, one day after the Dow and S&P 500 logged four-session winning streaks and the Nasdaq saw back-to-back gains.

The FDA and CDC announced Tuesday that both agencies had expanded eligibility for a second booster shot of the Pfizer or Moderna coronavirus vaccines for all adults over the age of 50.

The CDC and FDA made the decision without consulting their committees of independent vaccine experts.

“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.

U.S. stock futures dropped Wednesday, one day after Wall Street rebounded from Monday’s Fed-driven decline.

Moderna also asked the FDA to authorize its vaccine for children 6- to 11-years-old, the company announced Wednesday.

AstraZeneca has taken a roughly £25 million ($33 million) stake in U.K. health start-up Huma, according to a person familiar with the matter.

It’s been two years since Covid-19 crept across the globe, battered the U.S. economy and wreaked havoc on health-care systems unprepared to defend themselves against the novel pathogen. Now, as the latest wave of infections driven by the fast-spreading omicron variant rapidly subsides, many are beginning to question: Is Covid-19 becoming endemic? “There’s a high probability we’re moving into...

This week’s top trades from The Halftime Report’s Investment Committee

These are the stocks posting the largest moves in midday trading.

U.S. stock futures dropped Friday, but the S&P 500 remained on track for its best week since November 2020.

These are the stocks posting the largest moves before the bell.

Moderna CEO Stephane Bancel has sold more than 2.8 million shares since January 2020 at a total value of more than $408 million.

The stocks making the biggest moves in premarket trading include airlines, Coupa Software, GitLab, and more.

Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.

Two years after the World Health Organization declared the coronavirus a pandemic, public health experts warn not to become complacent.

Pfizer CEO Albert Bourla appeared on CNBC exactly two years after Covid was declared a pandemic by the WHO on March 11, 2020.